why choose us

First received: October 11, 2023

Clinical Trial: Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cancer

Study Type: OBSERVATIONAL


Official Title: Prospective Study to Evaluate Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Brief Summary: The purpose of this project is to collect body samples like blood and tissue and health information from people receiving immune-based treatment for cancer.The body samples and health information will be stored for future research to understand more about side effects related to immune-based treatments for cancer.

Read more